OverviewChartNewsTraderScreen

BVT Knock-Out PGR/  DE000VM65563  /

Frankfurt Zert./VONT
6/28/2024  10:34:51 AM Chg.+0.100 Bid11:48:09 AM Ask11:48:09 AM Underlying Strike price Expiration date Option type
7.390EUR +1.37% 7.400
Bid Size: 4,000		 7.520
Ask Size: 4,000		 Progressive Corporat... 134.06 USD 12/31/2078 Call
GlobeNewswire 7:00 AM XPPen to Showcase Diverse Innovative Products at Anime Expo 2024
GlobeNewswire 1:39 AM “LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire 12:30 AM Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determinatio...
Newsfile Corp 6/27 APFC Coin (APFC) Is Now Available for Trading on LBank Exchange
GlobeNewswire 6/27 UFL CONCLUDES INAUGURAL SEASON WITH SIGNIFICANT GROWTH ACROSS KEY CONSUMER METRICS
GlobeNewswire 6/27 GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators
GlobeNewswire 6/27 Treating Geographic Atrophy Remains a Tough Call for Ophthalmologists as They Voice Hesitancy to Pre...
GlobeNewswire 6/27 Copley Consulting Named to the 2024 Bob Scott’s Top 100 VARs List
GlobeNewswire 6/27 Almaden Announces Litigation Financing of up to US$9.5 million; Streamlines Arbitration Management
GlobeNewswire 6/25 argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...
GlobeNewswire 6/25 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial
GlobeNewswire 6/24 Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...
GlobeNewswire 6/24 4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire 6/24 Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...
GlobeNewswire 6/19 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
GlobeNewswire 6/18 Afamelanotide in fair-skinned Parkinson’s patients
GlobeNewswire 6/14 Progressive Reports May 2024 Results
GlobeNewswire 6/13 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire 6/12 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire 6/12 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire 6/11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 6/11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...
GlobeNewswire 6/11 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...
GlobeNewswire 6/10 LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire 6/10 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...